8 news items
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
GLPG
14 Jun 24
is produced using the company's innovative, decentralized T-cell manufacturing platform. The oral
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
ADAP
GLPG
30 May 24
and next-generation therapies, leveraging our innovative, decentralized cell therapy manufacturing platform. For patients with head & neck cancer
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune's TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
ADAP
GLPG
30 May 24
and next-generation therapies, leveraging our innovative, decentralized cell therapy manufacturing platform. For patients with head & neck cancer
Galapagos And Blood Centers Of America Collaborate To Expand Galapagos' Decentralized CAR-T Manufacturing Network In The U.S.
GLPG
15 May 24
role by supporting site initiation and onboarding to accelerate Galapagos' efforts and ensure consistent quality.Galapagos' innovative
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos' decentralized CAR-T manufacturing network in the U.S.
GLPG
15 May 24
. Galapagos' innovative, decentralized manufacturing platform could address many of the limitations that currently available CAR-T production is facing
mzq27c0azv6s940gr7dx4 igsfqna
GLPG
2 May 24
with a renewed focus, a differentiated and expanding R&D pipeline, and competitive technology platforms to bring innovation to patients around
qrttxxym27yza tevsx46v8nucibglnc5wtg8il
GLPG
4 Apr 24
. "We are committed to accelerating breakthrough innovations to extend the reach of CAR-T therapies to patients with rapidly progressing cancers," said
85zcqp 481t54xm7impukqe5mhsp4kxieomsvqurno12xx
GLPG
26 Mar 24
forward to working with the team and to contributing to the company's mission of pioneering on behalf of patients and accelerating innovation
- Prev
- 1
- Next